Benitec Biopharma (BNTC) Enterprise Value Growth (1y) (2020 - 2025)
Benitec Biopharma (BNTC) Enterprise Value Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.11% |
| Sep 30, 2025 | -39.38% |
| Jun 30, 2025 | -92.14% |
| Mar 31, 2025 | -796,692.31% |
| Dec 31, 2024 | -284.27% |
| Sep 30, 2024 | -162.26% |
| Jun 30, 2024 | -1,945.34% |
| Mar 31, 2024 | 99.80% |
| Dec 31, 2023 | -93.23% |
| Sep 30, 2023 | -56.71% |
| Jun 30, 2023 | 38.91% |
| Mar 31, 2023 | 23.36% |
| Dec 31, 2022 | 14.42% |
| Sep 30, 2022 | -5.18% |
| Jun 30, 2022 | 79.40% |
| Mar 31, 2022 | 28.01% |
| Dec 31, 2021 | 12.00% |
| Sep 30, 2021 | -110.74% |
| Jun 30, 2021 | -101.86% |
| Mar 31, 2021 | -5.16% |